SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-09-009524
Filing Date
2009-06-11
Accepted
2009-06-11 19:37:25
Documents
2
Period of Report
2009-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 11146
2 POWER OF ATTORNEY brinkley-poa.txt EX-24.TXT 3358
  Complete submission text file 0001179110-09-009524.txt   16322
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Issuer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 901 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Brinkley David L (Reporting) CIK: 0001302445 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-30319 | Film No.: 09888012